Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 110, 107083
Abstract
No abstract availableKeywords
Funding Information
- US Food and Drug Administration
This publication has 38 references indexed in Scilit:
- Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem CellsStem Cells Translational Medicine, 2013
- Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxinsCell Biology and Toxicology, 2012
- Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytesToxicology in Vitro, 2008
- Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytesToxicology Letters, 2007
- Drug-Related HepatotoxicityNew England Journal of Medicine, 2006
- Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the LiverThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Sulfation through the looking glass—recent advances in sulfotransferase research for the curiousThe Pharmacogenomics Journal, 2002
- Paracetamol (Acetaminophen)-Induced Toxicity: Molecular and Biochemical Mechanisms, Analogues and Protective ApproachesCritical Reviews in Toxicology, 2001
- Effects of cytochrome P450 inducers on 17α-ethinyloestradiol (EE2 ) conjugation by primary human hepatocytes1999
- Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liverHepatology, 1986